<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>2378539</identifier>
<setSpec>0020-3785</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Lázaro, M</dc:author>
<dc:author>Ayala, I</dc:author>
<dc:author>Soler Picart, M</dc:author>
<dc:author>Hernández Madrid, A</dc:author>
<dc:author>Pinto Corraliza, J</dc:author>
<dc:description xml:lang="en">Syncope or near-syncope can be the manifestation of a benign problem or a symptom of a life-threatening disease. Vasovagal syncope accounting for almost 70 per cent of cases. We identified 5 young patients who were presented to us with syncope or near-syncope. Diagnostic test, such as electrocardiogram, Holter monitoring and electrophysiological study identified only markers of hypervagotonia. We treated them with oral propantheline. By the time of follow up (20 months) none had recurrent episodes of syncope. Propantheline can be useful in patients with symptomatic vagotonia.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>1990 Mar-Apr </dc:date>
<dc:title xml:lang="es">Vagotonía sintomática en pacientes jóvenes. Datos clínicos y actitud terapéutica.</dc:title>
<dc:title xml:lang="en">[Symptomatic vagotonia in young patients. Clinical data and therapeutic approach].</dc:title>
<dc:publisher>Archivos del Instituto de Cardiologia de Mexico</dc:publisher>
</metadata>
</record>
</pubmed-document>
